Mylan Pharmaceuticals Inc recalls Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 ta
See all recalls from Mylan Pharmaceuticals Inc →Recalled Product
Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.
Hazard / Issue
Failed Dissolution Specifications
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for Acamprosate Calcium, Delayed-Release Tablets, →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime